Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

May 01, 1986; Volume 14,Issue 3
  • You have access
    Inhibitory effect of valproic acid on the disposition of carbamazepine and carbamazepine-10,11-epoxide in the rat.
    S L Chang and R H Levy
    Drug Metabolism and Disposition May 1986, 14 (3) 281-286;
  • You have access
    Phase II biotransformation of carcinogens/atherogens in cultured aortic tissues and cells. I. Sulfation of 3-hydroxy-benzo(a)pyrene.
    H Y Yang, M J Namkung, W L Nelson and M R Juchau
    Drug Metabolism and Disposition May 1986, 14 (3) 287-292;
  • You have access
    Phase II biotransformation of carcinogens/atherogens in cultured aortic tissues and cells. II. Glucuronidation of 3-hydroxy-benzo(a)pyrene.
    H Y Yang, M W Majesky, M J Namkung and M R Juchau
    Drug Metabolism and Disposition May 1986, 14 (3) 293-298;
  • You have access
    Aging: changes in distribution of diazepam and metabolites in the rat.
    A Rahman, H L Komiskey, W L Hayton and W P Weisenburger
    Drug Metabolism and Disposition May 1986, 14 (3) 299-302;
  • You have access
    Cytosolic glutathione S-transferases in various rat tissues differ in stereoselectivity with polycyclic arene and alkene oxide substrates.
    L A Dostal, A Aitio, C Harris, A V Bhatia, O Hernandez and J R Bend
    Drug Metabolism and Disposition May 1986, 14 (3) 303-309;
  • You have access
    Placental transfer of quazepam in mice.
    J M Hilbert, J Ning, S Symchowicz and N Zampaglione
    Drug Metabolism and Disposition May 1986, 14 (3) 310-312;
  • You have access
    Glutathione conjugates. Immobilized enzyme synthesis and characterization by fast atom bombardment mass spectrometry.
    S L Pallante, C A Lisek, D M Dulik and C Fenselau
    Drug Metabolism and Disposition May 1986, 14 (3) 313-318;
  • You have access
    Biotransformation of xenobiotics in individual rabbit hepatocytes. Application of microspectrofluorometry.
    T E Massey, T R Devereux and J R Fouts
    Drug Metabolism and Disposition May 1986, 14 (3) 319-324;
  • You have access
    The metabolism of 14C-cibenzoline in dogs and rats.
    A C Loh, T H Williams, J W Tilley, G J Sasso, A J Szuna, J J Carbone, V Toome and F J Leinweber
    Drug Metabolism and Disposition May 1986, 14 (3) 325-330;
  • You have access
    Dose-dependent pharmacokinetics of zoxazolamine in the rat.
    M Van der Graaff, N P Vermeulen, I E Crul and D D Breimer
    Drug Metabolism and Disposition May 1986, 14 (3) 331-335;
  • You have access
    Comparative metabolic disposition of oral doses of omeprazole in the dog, rat, and mouse.
    K J Hoffmann, L Renberg and S G Olovson
    Drug Metabolism and Disposition May 1986, 14 (3) 336-340;
  • You have access
    Identification of the main urinary metabolites of omeprazole after an oral dose to rats and dogs.
    K J Hoffmann
    Drug Metabolism and Disposition May 1986, 14 (3) 341-348;
  • You have access
    Clinical pharmacology of polyethylene glycol-L-asparaginase.
    D H Ho, N S Brown, A Yen, R Holmes, M Keating, A Abuchowski, R A Newman and I H Krakoff
    Drug Metabolism and Disposition May 1986, 14 (3) 349-352;
  • You have access
    Induction of monooxygenase and UDP-glucuronosyltransferase activities in primary cultures of rat hepatocytes.
    U Forster, G Luippold and L R Schwarz
    Drug Metabolism and Disposition May 1986, 14 (3) 353-360;
  • You have access
    Long-term pharmacokinetics of 2,2',4,4',5,5'-hexachlorobiphenyl (6-CB) in rats with constant adipose tissue mass.
    P A Wyss, S Mühlebach and M H Bickel
    Drug Metabolism and Disposition May 1986, 14 (3) 361-365;
  • You have access
    Testosterone metabolism in rat liver cytosolic androgen binding assays.
    G I Sunahara and G D Bellward
    Drug Metabolism and Disposition May 1986, 14 (3) 366-369;
  • You have access
    Renal transport of the glucuronides of paracetamol and p-nitrophenol in the dog.
    P Hekman, F G Russel and C A van Ginneken
    Drug Metabolism and Disposition May 1986, 14 (3) 370-371;
  • You have access
    Elimination kinetics of theophylline in the rabbit: effect of age and sex.
    A Canada, J Wilson and E Calabrese
    Drug Metabolism and Disposition May 1986, 14 (3) 372-374;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 14, Issue 3
1 May 1986
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Alternative P450 Splicing Redirects Human Drug Metabolism
  • Switch from CAR to PXR in the Presence of EGF
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics